A randomized controlled clinical trial to determine the optimum duration of G-CSF priming prior to BM stem cell harvesting

By Lowenthal Rm   Ragg Sj   Anderson J.   Nicholson L.   Harrup Ra   Tuck D.  

Cytotherapy, Vol. 9, Iss. 2, 2007-01 ,pp. : 158-164

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Hemopoietic Stem-Cell Harvesting and Transplantation Using G-CSF-Primed BM: Comparison with Unprimed BM and G-CSF-Primed PBSC

By Lowenthal RM   Tuck D   Tegg E   Marsden KA   Rees B   Luck J   Ragg S   Parker N   Kotlovsky N  

Cytotherapy, Vol. 1, Iss. 5, 1999-01 ,pp. : 409-416

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients

By Joshi S.   Miller K.   Jackson J.D.   Warkentin P.   Kessinger A.  

Cytotherapy, Vol. 2, Iss. 1, 2000-01 ,pp. : 15-24

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Soluble adhesion molecules (sICAM-1, sL-Selectin, sE-Selectin, sCD44) in healthy allogenic peripheral stem-cell donors primed with recombinant G-CSF

By Arslan Ö.   Akan H.   Arat M.   Dalva K.   Özcan M.   Gürman G.   Ilhan O.   Konuk N.   Beksaç M.   Uysal A.   Koç H.  

Cytotherapy, Vol. 2, Iss. 4, 2000-04 ,pp. : 259-265

Ashgate Publishing Ltd

Access to resources Recommend Favorite

A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study

By Fruehauf Stefan   Veldwijk Marlon Romano   Seeger Timon   Schubert Mario   Laufs Stephanie   Topaly Julian   Wuchter Patrick   Dillmann Falk   Eckstein Volker   Wenz Frederik   Goldschmidt Hartmut   Ho Anthony Dick   Calandra Gary  

Cytotherapy, Vol. 11, Iss. 8, 2009-11 ,pp. : 992-1001

Ashgate Publishing Ltd

Access to resources Recommend Favorite